Aug. 31, 2022 – The FDA on Wednesday granted emergency use authorization to Omicron-specific COVID-19 vaccines made by Pfizer/BioNTech and Moderna. The agency cited data to support the safety and efficacy of this next generation of mRNA vaccines targeted toward variants of concern. If you’ve been waiting to get a variant-specific booster shot, you may … Read more
June 8, 2022 — Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday. The neutralizing antibody response was eight times greater at 1 month following a 50-mcg dose with the booster containing both the original mRNA-1273 … Read more
Moderna on Monday announced that a booster dose of its COVID-19 vaccine increased levels of antibodies that fight the Omicron variant. Source link